Meditoxin

DRUG8 trials

Sponsors

Seoul National University Hospital, Medy-Tox

Conditions

Adult Cerebral PalsyAnhidrotic AreaDystoniaDystonic DisorderHealthyHyperhidrosisHyperhidrosis Primary Focal AxillaMasseter Muscle Hypertrophy

Phase 1

Pharmacodynamic and Safety of MEDITOXIN® in Healthy Male Volunteers

CompletedNCT03317717

Medy-ToxHealthy

Start: 2017-10-12End: 2018-01-30Updated: 2019-03-27

Treatment of MEDITOXIN® in Female Patients With Idiopathic Overactive Bladder

CompletedNCT03371342

Medy-ToxOveractive Bladder

Start: 2017-12-13End: 2018-09-05Updated: 2019-03-27

Anhidrotic Area and Safety of MEDITOXIN in Healthy Male Valunteers

CompletedNCT03647982

Medy-ToxAnhidrotic Area, Hyperhidrosis

Start: 2018-03-20End: 2018-11-20Updated: 2019-03-26

Phase 3

Meditoxin® Treatment in Patients With Cervical Dystonia

CompletedNCT03232320

Medy-ToxDystonia, Dystonic Disorder

Start: 2017-07-06End: 2018-11-05Updated: 2019-03-27

MEDITOXIN® Treatment in Subject With Benign Masseteric Hypertrophy

CompletedNCT03452345

Medy-ToxMasseter Muscle Hypertrophy

Start: 2018-04-09End: 2019-04-16Updated: 2020-07-28

Evaluate the Efficacy and Safety of MEDITOXIN in Treatment of Primary Axillary Hyperhidrosis

CompletedNCT03760198

Medy-ToxHyperhidrosis Primary Focal Axilla

Start: 2018-08-03End: 2019-09-17Updated: 2020-07-28

Phase 4

Efficacy and Safety of Meditoxin® Injection for Cervical Dystonia in Adults With Cerebral Palsy

CompletedNCT01860196

Seoul National University HospitalAdult Cerebral Palsy

Start: 2013-06-30End: 2017-06-30Updated: 2017-08-22

MEDITOXIN® Treatment in Subjects With Post-Stroke Upper Limb Spasticity

CompletedNCT03908580

Medy-ToxSpasticity, Muscle

Start: 2013-09-06End: 2015-03-31Updated: 2019-04-09